What Moves Like GMAB

Genmab A/S Pharmaceutical Preparations · Nasdaq

The tradable tickers whose daily moves track GMAB most closely over the past year, filtered to risk comparable with GMAB's own.

Closest match

IBB iShares Biotechnology ETF — 0.611 correlation over the past year, and 35% calmer than GMAB.

About GMAB

Annualised volatility 33.5%
Beta vs SPY 0.81
Market correlation 0.311
Traded per day $46.5M

As filed with the SEC balance sheet 2025-12-31

Total assets $12.87B
Total liabilities $7.03B
252 sessions to 2026-09-10 · GMAB volatility 33.5% annualised · $46.5M a day
Ticker 1-year correlation 3-year Volatility vs GMAB Risk What it is
IBB iShares Biotechnology ETF
0.611
0.544 0.65× 35% calmer Fund
FBT First Trust Amex Biotech Index Fund
0.582
0.539 0.65× 35% calmer Fund
XBI State Street SPDR S&P Biotech ETF
0.529
0.471 0.83× 17% calmer Fund
XPH State Street SPDR S&P Pharmaceuticals ETF
0.490
0.448 0.69× 31% calmer Fund
SBIO ALPS Medical Breakthroughs ETF
0.476
0.418 0.93× similar Fund
HQL abrdn Life Sciences Investors Shares of Beneficial Interest
0.472
0.443 0.68× 32% calmer
HQH abrdn Healthcare Investors Shares of Beneficial Interest
0.467
0.428 0.64× 36% calmer
NVS Novartis AG
0.412
0.361 0.79× 21% calmer Pharmaceutical Preparations
RYTM Rhythm Pharmaceuticals, Inc.
0.409
0.249 1.38× 38% choppier Pharmaceutical Preparations
GILD Gilead Sciences, Inc.
0.407
0.302 0.80× 20% calmer Biological Products, (No Diagnostic Substances)
SNY Sanofi
0.404
0.313 0.70× 30% calmer Pharmaceutical Preparations
AZN AstraZeneca PLC Ordinary Shares
0.396
0.417 0.85× 15% calmer Pharmaceutical Preparations
EZA iShares MSCI South Africa Index Fund
0.388
0.312 0.98× similar Fund
HALO Halozyme Therapeutics, Inc.
0.382
0.294 1.10× 10% choppier Biological Products, (No Diagnostic Substances)
EUFN iShares MSCI Europe Financials ETF
0.381
0.363 0.60× 40% calmer Fund
PPA Invesco Aerospace & Defense ETF
0.375
0.268 0.65× 36% calmer Fund
MXI iShares Global Materials ETF
0.374
0.374 0.65× 35% calmer Fund
AFK VanEck Africa Index ETF
0.373
0.299 0.84× 16% calmer Fund
ARGX argenx SE
0.372
0.309 1.04× similar Biological Products, (No Diagnostic Substances)
IDHQ Invesco S&P International Developed Quality ETF
0.370
0.399 0.62× 38% calmer Fund
EXEL Exelixis, Inc.
0.370
0.216 1.11× 11% choppier Biological Products, (No Diagnostic Substances)
PFE Pfizer, Inc.
0.369
0.316 0.70× 30% calmer Pharmaceutical Preparations
LYG Lloyds Banking Group Plc American Depositary Shares
0.369
0.311 0.87× 13% calmer Commercial Banks, Nec
REGN Regeneron Pharmaceuticals, Inc.
0.367
0.305 1.00× similar Pharmaceutical Preparations
BSAC Banco Santander - Chile ADS
0.367
0.284 0.86× 14% calmer Commercial Banks, Nec

Showing 25 of 30 tickers that qualified. Correlation is of daily returns; 1.000 would mean moving in lockstep, 0.000 no relationship at all.

What this is for

Three questions, one number behind all of them.

How to read the two correlation columns

The one-year figure is what the relationship looks like now. The three-year figure is what it has looked like over a longer stretch. Comparing them is the point: when they agree, the relationship is structural and likely to hold. When the one-year number is far below the three-year one, something has changed — a shift in business mix, an index reconstitution, a sector that has stopped moving together — and the recent figure is the one to trust less, not more.

Correlation measures whether two things move together, not whether they move by the same amount. That is why the volatility column is there. Two tickers can correlate at 0.99 while one swings half again as hard, and swapping one for the other would quietly change how much risk you are carrying.

What was deliberately left out

Ranking purely by correlation produces answers that are mathematically perfect and practically useless. The closest matches to AAPL by raw correlation are leveraged AAPL funds at 0.999 — correct, and not replacements for anything. Four filters run before a ticker is allowed to appear:

Where all of that leaves a ticker with no close match, the page says so. A stock with no substitute is a real and useful finding, and inventing a loose one to fill the table would be worse than an empty answer.

Limits, stated up front

Where the numbers come from

Correlations are computed in-house from a daily price history and rebuilt every night. What gets published is the derived statistic — a correlation coefficient, a volatility ratio, an observation count — and nothing from which a price or return series could be reconstructed. The rest of the Markets section is on the Markets overview, including futures positioning extremes and SEC Form 4 insider transactions.